Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0X6UV
|
||||
Former ID |
DNC004904
|
||||
Drug Name |
4-fluorobenzaldehyde O-benzoyloxime
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C14H10FNO2
|
||||
Canonical SMILES |
C1=CC=C(C=C1)C(=O)ON=CC2=CC=C(C=C2)F
|
||||
InChI |
1S/C14H10FNO2/c15-13-8-6-11(7-9-13)10-16-18-14(17)12-4-2-1-3-5-12/h1-10H/b16-10+
|
||||
InChIKey |
DIEBAKUPBFEXAP-MHWRWJLKSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Lipoprotein-associated phospholipase A2 | Target Info | Inhibitor | [1] | |
KEGG Pathway | Ether lipid metabolism | ||||
Metabolic pathways | |||||
Biosynthesis of antibiotics | |||||
Pathway Interaction Database | Lissencephaly gene (LIS1) in neuronal migration and development | ||||
WikiPathways | IL1 and megakaryotyces in obesity | ||||
Synthesis, Secretion, and Deacylation of Ghrelin | |||||
References | |||||
REF 1 | Bioorg Med Chem Lett. 2006 Nov 1;16(21):5576-9. Epub 2006 Aug 21.Potent inhibitors of lipoprotein-associated phospholipase A(2): benzaldehyde O-heterocycle-4-carbonyloxime. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.